Status:
ACTIVE_NOT_RECRUITING
Virtual Reality to Reduce Pre-procedure Anxiety Prior ECT
Lead Sponsor:
Sunnybrook Health Sciences Centre
Conditions:
ECT
Electroconvulsive Therapy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Lack of patient knowledge about ECT (electroconvulsive therapy) is a leading cause of treatment fear with 60% of ECT patients reporting high levels of anxiety. The purpose of this study is to determi...
Detailed Description
Virtual reality (VR) is increasingly being used in healthcare, in particular as a form of exposure therapy for patients with psychiatric disorders. It immerses patients into hospital-based procedures....
Eligibility Criteria
Inclusion
- Age ≥18
- First time undergoing ECT within the last year
- Outpatient/inpatient recommended for ECT
- Within 2-4 days of ECT procedure or no ECT within the past year
- Referred by psychiatrist
- Able to understand English
- Able to watch and respond to questions
Exclusion
- Lack of patient consent or capacity to give consent
- Visual and hearing impairments precluding the ability to watch or listen to video
- History of significant motion sickness (i.e. occur during exposure to physical, visual and virtual motion, cybersickness verbally declared by patient)
Key Trial Info
Start Date :
November 27 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT04291196
Start Date
November 27 2020
End Date
December 1 2025
Last Update
November 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada, M4N 3M5